Cargando…
Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population
The WHO has approved the use of several vaccines during the COVID-19 pandemic; experience over the last 2 years has indicated that dose demand can only be covered using more than one design. Therefore, having scientific evidence of the performance of the different vaccines applied in a country is hi...
Autores principales: | Fernandes-Matano, Larissa, Salas-Lais, Angel Gustavo, Grajales-Muñiz, Concepción, Hernández-Ávila, Mauricio, Garfias-Becerra, Yonathan Omar, Rodríguez-Sepúlveda, Mario César, Segura-Sánchez, Carlos, Montes-Herrera, Daniel, Mendoza-Sánchez, Denisse, Angeles-Martínez, Javier, Santos Coy-Arechavaleta, Andrea, Alvarado-Yaah, Julio Elías, Santacruz-Tinoco, Clara Esperanza, Ramón-Gallegos, Eva, Muñoz-Medina, José Esteban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927513/ https://www.ncbi.nlm.nih.gov/pubmed/36602375 http://dx.doi.org/10.1128/spectrum.02376-22 |
Ejemplares similares
-
Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac
por: Nantanee, Rapisa, et al.
Publicado: (2022) -
Immunogenicity and reactogenicity after heterologous prime-boost vaccination with CoronaVac and ChAdox1 nCov-19 (AZD1222) vaccines
por: Cohen, Guy, et al.
Publicado: (2022) -
Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection
por: Suah, Jing Lian, et al.
Publicado: (2022) -
Prevalence of COVID-19 vaccines (Sputnik V, AZD-1222, and Covaxin) side effects among healthcare workers in Birjand city, Iran
por: Zare, Hamed, et al.
Publicado: (2021) -
Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac)
por: Jeewandara, Chandima, et al.
Publicado: (2022)